四天三板寧波方正:擬投資的動力鋰電池精密結構件項目與目前公司主營業務沒有明顯協同性
格隆匯11月15日丨寧波方正發佈異動公告,目前公司客戶、供應商與鋰電池結精密構件業務沒有顯著關聯度,公司前五大客戶、供應商與鋰電池精密結構件業務無關聯,公司擬投資的動力鋰電池精密結構件項目與目前公司主營業務沒有明顯協同性。目前新能源鋰電池精密結構件項目實施主體合資公司還在籌備階段,團隊正在組建中,公司及關聯方不具備鋰電池精密結構件具體產品的相應生產技術與在研項目,同時目前公司鋰電池結構件業務無明確客戶,未來可能因技術研發、認證體系、客戶訂單、工藝技術不達預期等因素導致項目建設延期或終止的風險。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.